Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Overview of attention for article published in New England Journal of Medicine, September 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 71 news outlets
blogs: 7 blogs
twitter: 554 X users
facebook: 4 Facebook pages
wikipedia: 1 Wikipedia page

reddit: 4 Redditors
video: 6 YouTube creators
guideline: 7 clinical guideline sources
bluesky: 12 Bluesky users
podcasts: 13 podcasts

Readers on

mendeley: 567 Mendeley

So far, Altmetric has seen 143 news stories from 71 outlets.

Kerendia Approved for Heart Failure With Left Ventricular Ejection Fraction ≥40 Percent

Physician's Weekly, 12 Oct 2026

Kerendia is a nonsteroidal mineralocorticoid receptor antagonist that selectively blocks overactivation of mineralocorticoid…

Medicamento usado para os rins agora pode tratar o coração | Veja Saúde

Veja Saúde, 12 Aug 2026

Oferta Relâmpago: Revista Impressa por R$ 9,90/mês e ganhe descontos e cashback.

NICE Recommends New Nonsteroidal MRA for Heart Failure Medscape News UK8 hours ago

Medscape, 16 Jul 2026

NICE has recommended finerenone (Kerendia, Bayer) in final draft guidance as a treatment option for adults with symptomatic…

HFpEF Diagnosis Enters a New Era

Medscape, 25 Jun 2026

Heart failure with preserved ejection fraction (HFpEF) has become the most common subtype of heart failure, accounting for more…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 139 additional news stories.